BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12776201)

  • 1. Genetic analysis identifies putative tumor suppressor sites at 2q35-q36.1 and 2q36.3-q37.1 involved in cervical cancer progression.
    Narayan G; Pulido HA; Koul S; Lu XY; Harris CP; Yeh YA; Vargas H; Posso H; Terry MB; Gissmann L; Schneider A; Mansukhani M; Rao PH; Murty VV
    Oncogene; 2003 May; 22(22):3489-99. PubMed ID: 12776201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma.
    Rao PH; Arias-Pulido H; Lu XY; Harris CP; Vargas H; Zhang FF; Narayan G; Schneider A; Terry MB; Murty VV
    BMC Cancer; 2004 Feb; 4():5. PubMed ID: 15018632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the sites of putative tumor suppressor genes at 6p25 and 6p21.3 in cervical carcinoma: occurrence of allelic deletions in precancerous lesions.
    Chatterjee A; Pulido HA; Koul S; Beleño N; Perilla A; Posso H; Manusukhani M; Murty VV
    Cancer Res; 2001 Mar; 61(5):2119-23. PubMed ID: 11280775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer.
    Pulido HA; Fakruddin MJ; Chatterjee A; Esplin ED; Beleño N; Martinez G; Posso H; Evans GA; Murty VV
    Cancer Res; 2000 Dec; 60(23):6677-82. PubMed ID: 11118052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
    Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
    Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High resolution analysis of chromosome 3p alterations in cervical carcinoma.
    Larson AA; Kern S; Curtiss S; Gordon R; Cavenee WK; Hampton GM
    Cancer Res; 1997 Sep; 57(18):4082-90. PubMed ID: 9307297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping common deleted regions on 5p15 in cervical carcinoma and their occurrence in precancerous lesions.
    Arias-Pulido H; Narayan G; Vargas H; Mansukhani M; Murty VV
    Mol Cancer; 2002 Oct; 1():3. PubMed ID: 12392596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions at chromosome 2q and 12p are early and frequent molecular alterations in bronchial epithelium and NSCLC of long-term smokers.
    Grepmeier U; Dietmaier W; Merk J; Wild PJ; Obermann EC; Pfeifer M; Hofstaedter F; Hartmann A; Woenckhaus M
    Int J Oncol; 2005 Aug; 27(2):481-8. PubMed ID: 16010431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer.
    Cengiz B; Gunduz M; Nagatsuka H; Beder L; Gunduz E; Tamamura R; Mahmut N; Fukushima K; Ali MA; Naomoto Y; Shimizu K; Nagai N
    Oral Oncol; 2007 Mar; 43(3):241-7. PubMed ID: 16857411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23.
    Zhang Z; Gerhard DS; Nguyen L; Li J; Traugott A; Huettner PC; Rader JS
    Genes Chromosomes Cancer; 2005 May; 43(1):95-103. PubMed ID: 15672406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
    Yu MY; Tong JH; Chan PK; Lee TL; Chan MW; Chan AW; Lo KW; To KF
    Int J Cancer; 2003 Jun; 105(2):204-9. PubMed ID: 12673680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of molecular alterations in chromosome 8 associated with the development of uterine cervical carcinoma of Indian patients.
    Bhattacharya N; Singh RK; Mondal S; Roy A; Mondal R; Roychowdhury S; Panda CK
    Gynecol Oncol; 2004 Nov; 95(2):352-62. PubMed ID: 15491757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
    Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
    Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene.
    Singh RK; Indra D; Mitra S; Mondal RK; Basu PS; Roy A; Roychowdhury S; Panda CK
    Hum Genet; 2007 Aug; 122(1):71-81. PubMed ID: 17609981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.
    Srivatsan ES; Chakrabarti R; Zainabadi K; Pack SD; Benyamini P; Mendonca MS; Yang PK; Kang K; Motamedi D; Sawicki MP; Zhuang Z; Jesudasan RA; Bengtsson U; Sun C; Roe BA; Stanbridge EJ; Wilczynski SP; Redpath JL
    Oncogene; 2002 Aug; 21(36):5631-42. PubMed ID: 12165862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
    Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
    Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma.
    Takita J; Yang HW; Chen YY; Hanada R; Yamamoto K; Teitz T; Kidd V; Hayashi Y
    Oncogene; 2001 Jul; 20(32):4424-32. PubMed ID: 11466626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas.
    Senchenko V; Liu J; Braga E; Mazurenko N; Loginov W; Seryogin Y; Bazov I; Protopopov A; Kisseljov FL; Kashuba V; Lerman MI; Klein G; Zabarovsky ER
    Oncogene; 2003 May; 22(19):2984-92. PubMed ID: 12771950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X chromosomal and autosomal loss of heterozygosity and microsatellite instability in human cervical carcinoma.
    Edelmann J; Richter K; Hänel C; Hering S; Horn LC
    Int J Gynecol Cancer; 2006; 16(3):1248-53. PubMed ID: 16803513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.